Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CYTR $5.01 0.5100 +11.33%
ONCY $0.76 0.0710 +10.29%
FATE $5.96 0.5500 +10.17%
FPRX $24.16 1.6600 +7.38%
AVEO $1.84 0.1200 +6.98%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

BPTH $1.44 -0.1200 -7.69%
KERX $11.45 -0.8300 -6.76%
SNSS $2.64 -0.1800 -6.38%
BDSI $9.46 -0.5600 -5.59%
CLVS $86.15 -4.8400 -5.32%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Next > | Last >>

Cancer Prevention Efforts in the U.S. a Mixed Bag

(American Cancer Society) Apr 1, 2015 - While there has been substantial progress in some cancer control efforts in the past several decades, like reductions in smoking and increased utilization of cancer screening, progress in some areas is lagging, according to a new report.
read press release 

Roche Open to Alliances in Hunt for Cancer Drug Combinations

(Reuters) Apr 1, 2015 - Roche, the world's largest cancer drugmaker, is ready to collaborate with rivals to find new combination therapies for multi-pronged treatments, its chief executive said.
read article 

Study Supports Laparoscopy For Rectal Cancer

(WebMD/HealthDay News) Apr 1, 2015 - Patients with localized rectal cancer may achieve similar survival rates by having minimally invasive laparoscopic surgery, instead of more invasive open surgery, a European study finds.
read article 

Physical Activity Benefits Lung Cancer Patients and Survivors

(IASLC) Apr 1, 2015 - Exercise and physical activity should be considered as therapeutic options for lung cancer as they have been shown to reduce symptoms, increase exercise tolerance, improve quality of life, and potentially reduce length of hospital stay and complications following surgery for lung cancer.
read press release 

Circulating Tumor DNA in Blood Can Predict Recurrence of the Most Common Type of Lymphoma

(NCI) Apr 1, 2015 - Measurement of circulating tumor DNA (ctDNA) in blood can be used to detect disease recurrence in patients with a curable form of cancer known as diffuse large B-cell lymphoma (DLBCL).
read press release 

Novartis Announces FDA Approval for Jadenu™ to Simplify Treatment Administration for Patients with Chronic Iron Overload

(MarketWatch) Mar 30, 2015 - The FDA has approved Jadenu(TM) (deferasirox) tablets, a new oral formulation of Exjade® (deferasirox) tablets for oral suspension, for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes (NTDT) in patients 10 years of age and older.
read article 

The Healing Power of Your Own Medical Records

(New York Times) Mar 31, 2015 - There is evidence that letting patients see their medical files helps them take better care of themselves, but the medical establishment still resists sharing the data.
read article 

Amgen Loses Another Round in its Battle to Fend Off a Biosimilar Rival

(Wall Street Journal/Pharmalot blog) Mar 30, 2015 - For the second time this month, Amgen has lost a battle over its effort to block a biosimilar version of its Neupogen drug, a $5.7 billion seller that is used to fend off infections during chemotherapy.
read article (paid subscription required) 

NIH Forms Team of Experts to Chart Course for the President’s Precision Medicine Initiative Research Network

(NIH) Mar 30, 2015 - A newly created team of experts in precision medicine and large clinical research studies will seek public input from the large and diverse stakeholder community interested in the development of the President’s Precision Medicine Initiative and articulate the vision for building the national participant group for the Initiative.
read press release 

FDA Warning on Ferumoxytol

(HCP Live) Mar 30, 2015 - The US Food and Drug Administration (FDA) issued a strong warning on a drug used to treat iron deficiency anemia in patients with chronic kidney disease.
read article 

Fight Over High-Cost Drugs to Intensify After Catamaran Deal

(Bloomberg) Mar 30, 2015 - UnitedHealth Group Inc.’s deal for Catamaran Corp. is going to build a bigger pharmacy benefit manager. It will also put even more pressure on drugmakers’ high prices for breakthrough medicines.
read article 

NCCN Holds Fourth Annual State Oncology Society Forum

(NCCN) Mar 31, 2015 - The fourth annual state oncology society forum, held in conjunction with NCCN’s 20th Annual Conference, examined accountable care, payment reform, and best practices from community oncologists.
read press release 

Novartis' Zykadia Clears First Step in UK Early Access Scheme

(PharmaTimes [UK]) Mar 31, 2015 - Novartis’ investigational lung cancer drug Zykadia (ceritinib) been awarded Promising Innovative Medicine status in the UK, completing the first stage of the country’s Early Access to Medicines Scheme.
read article 

ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period

(TheStreet) Mar 30, 2015 - The American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology (ASCO) today released a draft of a clinical practice guideline on the use of molecular marker testing for patients with primary or metastatic colorectal carcinoma.
read article 

Guidance Issued for Endometrial Cancer, Hints for Diagnosis

(Medscape Medical News) Mar 30, 2015 - The American College of Obstetricians and Gynecologists and the Society of Gynecologic Oncology have issued new guidance for endometrial cancer.
read article (free registration required) 

Brain Cancer: Did '60 Minutes' Report Raise False Hope?

(MedPage Today) Mar 30, 2015 - Glioblastoma virotherapy touted on CBS program is promising but preliminary.
read article (free registration required) 

Doctors With Cancer Push California To Allow Aid In Dying

(NPR/Shots blog) Mar 30, 2015 - Dr. Dan Swangard doesn't know if he would take lethal medications to hasten death. But as someone with metastatic cancer, he wants to have that choice. He's part of a suit to change California law.
read article 

A Week of Excitement and Hope: Communicating the Story of Cancer

(NCI Update [blog]) Mar 30, 2015 - NCI is the engine that has fueled cancer research and provided the intellectual infrastructure critical to continued progress.
read article 

Looking to the Future of Childhood Cancer Research

(NCI Update [blog]) Mar 31, 2015 - Two overarching strategies to meet the challenges of childhood cancer research are precision medicine and immunotherapy.
read article 

Making Sense of Key Cancer Reports

(NCI Update [blog]) Mar 30, 2015 - The Annual Report to the Nation, issued today, is one of several regularly released reports that provide information on important cancer trends in the United States.
read article 

The Condition Cancer Research Is In

(New York Times) Mar 30, 2015 - Dr. Harold Varmus, the departing director of the National Cancer Institute, addresses funding challenges and the state of the fight against the disease.
read article 

The CNIO Identifies a New Gene Involved in Hereditary Neuroendocrine Tumors

(CNIO [Madrid, Spain]) Mar 30, 2015 - Researchers in the Hereditary Endocrine Cancer Group of the Spanish National Cancer Research Centre (CNIO) have described the presence of mutations in the MDH2 gene, in a family with very rare neuroendocrine tumours associated with a high hereditary component.
read press release 

Fasting and Less-Toxic Cancer Drug May Work as Well as Chemotherapy

(USC) Mar 30, 2015 - In back-to-back studies, researchers show how fasting combined with a class of cancer-inhibiting drugs can starve colorectal, breast and lung cancer cells.
read press release 

Mount Sinai Researchers Discover Genetic Origins of Myelodysplastic Syndrome Using Stem Cells

(Mount Sinai Hospital) Mar 27, 2015 - Researchers at Icahn School of Medicine at Mount Sinai have taken mature blood cells from patients with myelodysplastic syndrome (MDS) and reprogramed them back into induced pluripotent stem cells (iPSCs) to study the genetic origins of this rare blood cancer.
read press release 

Researchers Develop New Potential Drug for Rare Leukemia

(U-M Health System) Mar 30, 2015 - Researchers at the University of Michigan Comprehensive Cancer Center have developed a new drug candidate that shows potential in laboratory studies against a rare type of acute leukemia. And additional studies suggest the same compound could play a role in prostate cancer treatment as well.
read press release